A New Pain Medication Could Reinforce the Disastrous Crackdown on Prescription Opioids
When the government is systematically interfering with medical decisions, a non-opioid alternative may not actually increase treatment options.
When the government is systematically interfering with medical decisions, a non-opioid alternative may not actually increase treatment options.
Painkiller reflects an indiscriminate anti-opioid bias that has caused needless suffering.
The emergence of the animal tranquilizer as an opioid adulterant illustrates once again how the war on drugs makes drug use more dangerous.
On Friday, the DEA unveiled a plan to restrict doctors' ability to prescribe controlled drugs over telehealth.
The CDC’s revised prescribing guidelines retain an anti-opioid bias and do nothing to reverse the harmful policies inspired by the 2016 version.
Over 88 percent of opioid overdose deaths now involve either heroin or fentanyl. Targeting prescriptions is not an efficient way to address mortality.
The year’s highlights in buck passing feature petulant politicians, brazen bureaucrats, careless cops, loony lawyers, and junky journalists.
The damage done by the original guidelines, including undertreatment and abrupt dose reductions, could have been avoided if the CDC had not presumed to advise doctors on how to treat pain.
The CDC, which issued disastrous pain treatment advice in 2016, is still pushing a narrative contradicted by recent data.
The unanimous decision will rein in prosecutions that have long had a chilling effect on pain treatment.
The Supreme Court is considering what standard should apply to prescribers accused of violating the Controlled Substances Act.
Patients suffer when physicians who prescribe opioids in good faith can face decades in prison.
The proposed guidelines emphasize the need for individualized treatment and collaboration with patients.
Restrictions on pain medication have undermined patient care while making drug use more lethal.
The Hulu miniseries portrays opioid pain medication as unacceptably dangerous in nearly every context.
Undertreatment of pain is a real problem, and bona fide patients rarely become addicted to their medication.
The justices rejected a broad definition of "public nuisance" that would cover the manufacture of pain medication.
A drug that treats opioid addiction may also be abused. That’s not a good reason to restrict access.
A California judge said the four jurisdictions that filed the lawsuit failed to prove a "public nuisance" or "false advertising."
The study highlights the dangers that government-encouraged "tapering" poses to patients on long-term opioid therapy.
Restricting access to pain medication drove nonmedical users toward black-market substitutes.
Two recent studies show how ham-handed efforts to reduce opioid prescriptions undermine medical care.
The crackdown on pain medication made drug use more dangerous and did nothing to address the factors driving "deaths of despair."
The data do not support the conventional wisdom that pain pill prescriptions are driving drug-related fatalities.
The original formulation of OxyContin didn’t create the opioid crisis, argues psychiatrist Sally Satel, and removing it from the market didn’t make the problem go away.
After a slight drop in 2018, fatalities involving opioids jumped last year, setting a new record that is apt to be broken this year.
The $8.3 billion DOJ settlement is part of a crackdown that has perversely pushed drug users toward more dangerous substitutes.
A brief supporting the company's appeal argues that its discussion of pain treatment was constitutionally protected.
It's an interesting strategy for a president who ran in 2016 on a Nixonian "law and order" platform.
Illicit fentanyl and heroin accounted for the vast majority of opioid-related deaths, while only 1 percent of cases involved drugs for which people had prescriptions.
The discussion during last night's debate grossly exaggerated the role of prescription pain pills in opioid-related deaths.
Blaming opioid makers for the "opioid crisis" may be emotionally satisfying, but the reality is more complicated.
Can legal sales of prescription opioids constitute a nuisance? Two decisions, based on nearly identical statutes, reach diametrically opposed conclusions.
Nonmedical use of prescription analgesics did not become more common, but it did become more dangerous.
The data reinforce the point that there is no straightforward relationship between pain pill consumption and overdoses.
The causes of opioid-related deaths are more complicated than "too many pain pills."
The FDA Opioid Labeling Accuracy Act would aggravate the widespread problem of involuntary dose reductions and patient abandonment.
The decision by the New Hampshire Board of Medicine suggests state officials are beginning to recognize the harm caused by the crackdown on pain pills.
The agency’s acknowledgment of the suffering caused by its prescribing advice may be too little, too late.
The CDC decries abrupt, involuntary dose reductions and patient abandonment without acknowledging its responsibility for those unintended but foreseeable consequences.
The CDC's advice has been widely interpreted as requiring involuntary tapering of medication so it does not exceed an arbitrary threshold.
If the senator really believed "all health care should be between doctors and patients," she would not be proposing a one-size-fits-all rule for pain treatment.
The agency's opioid advice has led to arbitrary dose reductions, denial of care, senseless suffering, and suicide.
Only if you are using heroin, fentanyl, or dangerous drug mixtures
A new Medicare prescription rule will aggravate undertreatment of pain.
The crackdown on analgesics continues to push nonmedical users toward deadlier alternatives.